Hodges Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-61,760
Closed -$5.37M 206
2020
Q2
$5.37M Sell
61,760
-74,800
-55% -$5.98M 1.1% 25
2020
Q1
$7.92M Sell
136,560
-43,325
-24% -$3.52M 2.03% 8
2019
Q4
$16.6M Buy
179,885
+11,935
+7% +$1.05M 2.19% 6
2019
Q3
$15.2M Buy
167,950
+9,630
+6% +$1.1M 1.75% 12
2019
Q2
$20.4M Sell
158,320
-22,565
-12% -$2.27M 2.21% 5
2019
Q1
$15.7M Sell
180,885
-34,615
-16% -$2.95M 1.58% 12
2018
Q4
$13.6M Sell
215,500
-29,270
-12% -$2.01M 1.53% 16
2018
Q3
$19.3M Buy
244,770
+29,930
+14% +$1.95M 1.42% 18
2018
Q2
$12.8M Sell
214,840
-59,060
-22% -$3.18M 0.95% 33
2018
Q1
$11M Sell
273,900
-25,985
-9% -$1.27M 0.87% 34
2017
Q4
$15.8M Sell
299,885
-98,485
-25% -$5.26M 1.16% 21
2017
Q3
$18.8M Buy
+398,370
New +$16M 1.27% 20

Other funds holding EXAS

Hodges Capital Management's EXAS Position: Q3 2020 in Review

Hodges Capital Management sold out of Exact Sciences (EXAS) in Q3 2020, closing a stake of 61,760 shares — an estimated $5.37M sold.

Hodges Capital Management first reported a position in EXAS in Q3 2017 and held it in 12 quarters. The position peaked at $20.4M in Q2 2019. 517 funds tracked by Wall St. Rank hold EXAS as of Q3 2020.

  • Hodges Capital Management reported no remaining Exact Sciences position as of Q3 2020 after selling out during the quarter.
  • Hodges Capital Management sold 61,760 Exact Sciences shares in Q3 2020, an estimated $5.37M.
  • Hodges Capital Management first reported a position in Exact Sciences in Q3 2017 and held it in 12 quarters.
  • Hodges Capital Management's Exact Sciences position peaked at $20.4M in Q2 2019.
  • 517 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2020.

Based on Hodges Capital Management's 13F filing for Q3 2020, filed 15 Oct 2020.